JLE

Epileptic Disorders

MENU

Patient and physician preferences: impact on treatment effectiveness Volume 14, issue 3, September 2012

Adair J. The Hawthorne effect: a reconsideration of the methodological artifact. J Appl Psychol 1984 ; 69 : 334-345.

Barnett AG, van der Pols JC, Dobson A.J. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005 ; 34 : 215-220.

Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. J Neurosci 1999 ; 19 : 3639-3648.

Brewin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ 1989 ; 299 : 313-315.

Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. I: Medical. Stat Med 1989 ; 8 : 441-454.

Cook TD, Campbell D.T. Quasi-experimentation - design and analysis issues for field settings. Chicago : Rand McNally, 1979.

de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001 ; 293 : 1164-1166.

Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010 ; 375 : 686-695.

Gallahan WC, Case D, Bloomfeld R.S. An analysis of the placebo effect in Crohn's disease over time. Aliment Pharmacol Ther 2010 ; 31 : 102-107.

Gracely RH, Dubner R, Deeter WR, Wolskee P.J. Clinicians’ expectations influence placebo analgesia. Lancet 1985 ; 1 : 43.

Guekht AB, Korczyn AD, Bondareva IB, Gusev E.I. Placebo responses in randomized trials of antiepileptic drugs. Epilepsy Behav 2010 ; 17 : 64-69.

King M, Nazareth I, Lampe F, et al. Impact of participant and physician intervention preferences on randomized trials: a systematic review. JAMA 2005 ; 293 : 1089-1099.

King M, Nazareth I, Lampe F, et al. Conceptual framework and systematic review of the effects of participants’ and professionals’ preferences in randomised controlled trials. Health Technol Assess 2005b; 9: 1-186, iii-iv.

Lee BI, Yi S, Hong SB, et al. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Epilepsia 2009 ; 50 : 464-474.

MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black A.M. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess 2000 ; 4 : 1-154.

Marson AG, Williamson P.R. Interpreting regulatory trials in epilepsy. Curr Opin Neurol 2009 ; 22 : 167-173.

Preference Collaborative Review GroupPatients’ preferences within randomised trials: systematic review and patient level meta-analysis. BMJ 2008 ; 337 : a1864.

Rheims S, Cucherat M, Arzimanoglou A, Ryvlin P. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 2008 ; 5 : e166.

Rheims S, Perucca E, Cucherat M, Ryvlin P. Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis. Epilepsia 2011 ; 52 : 219-233.

Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 2006 ; 46 : 101-109.

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson W.S. Evidence based medicine: what it is and what it isn’t. BMJ 1996 ; 312 : 71-72.

Sandler A. Placebo effects in developmental disabilities: implications for research and practice. Ment Retard Dev Disabil Res Rev 2005 ; 11 : 164-170.

Schulz KF, Grimes D.A. Blinding in randomised trials: hiding who got what. Lancet 2002 ; 359 : 696-700.

Schulz KF, Chalmers I, Hayes RJ, Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995 ; 273 : 408-412.

Shinnar S, Pellock J.M. The trials and tribulations of pediatric drug trials. Neurology 2005 ; 65 : 1348-1349.

Stolk P, Ten Berg MJ, Hemels ME, Einarson T.R. Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother 2003 ; 37 : 1891-1899.

Sysko R, Walsh B.T. A systematic review of placebo response in studies of bipolar mania. J Clin Psychiatry 2007 ; 68 : 1213-1217.

Thompson W.G. Placebos: a review of the placebo response. Am J Gastroenterol 2000 ; 95 : 1637-1643.

Torgerson DJ, Klaber-Moffett J, Russell I.T. Patient preferences in randomised trials: threat or opportunity?. J Health Serv Res Policy 1996 ; 1 : 194-197.

Volkow ND, Wang GJ, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003 ; 23 : 11461-21148.

Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 2002 ; 287 : 1840-1847.

Xiao Z, Li JM, Wang XF, et al. Efficacy and safety of levetiracetam (3,000 mg/day) as an adjunctive therapy in Chinese patients with refractory partial seizures. Eur Neurol 2009 ; 61 : 233-239.